Wall Street expects a year-over-year decline in earnings on lower revenues when Magna (MGA) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 1. On the other ...

Core Insights - AMERISAFE, Inc. (AMSF) reported second-quarter adjusted earnings per share of 53 cents, missing the Zacks Consensus Estimate by 3.6% and reflecting an 8.6% year-over-year decline [1][8] - Operating revenues reached $76.1 million, showing a slight year-over-year increase but falling short of the consensus mark by 1.5% [1][8] Financial Performance - Net premiums earned increased by 1.1% year over year to $69.4 million, but were below the Zacks Consensus Estimate of $70.5 million, supported by strong retention rates and new business growth [3] - Net investment income dropped 10.2% year over year to $6.7 million due to reduced investable assets, although it exceeded the consensus estimate of $6.6 million [3] - Pre-tax underwriting profit was reported at $5.7 million, down 12.2% year over year [4] - Total expenses rose by 2.5% year over year to $63.6 million, driven by higher loss and loss adjustment expenses [4][8] - Operating net income decreased by 9.7% year over year to $10 million [4] Ratios and Metrics - The net combined ratio was 91.7%, worsening by 120 basis points year over year and exceeding the consensus estimate of 90.5% [5] - Return on average equity improved by 660 basis points year over year to 21.2% [6] Capital Management - AMERISAFE repurchased 62.8 thousand common shares for $2.8 million in the second quarter and reauthorized a $25 million share repurchase program [7] Dividend Announcement - A quarterly cash dividend of 39 cents per share was announced, scheduled for payment on September 26, 2025, to shareholders of record as of September 12 [9]

Collegium Pharmaceutical (COLL) closed the last trading session at $32.11, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $43 indicates a 33.9% upside potential.The average comprises five short-term price targets ranging from a low of $37.00 to a high of $50.00, with a standard deviation of $5.1. While the lowest estimate indicates an increase of 15.2% from the curren ...

Iridium Communications (IRDM) has been beaten down lately with too much selling pressure. While the stock has lost 14.4% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and ch ...

A downtrend has been apparent in Royal Gold (RGLD) lately with too much selling pressure. The stock has declined 13.6% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. T ...

Ponce Financial (PDLB) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +47.06%. A quarter ago, it was expected that this holding company of Ponce Bank would post earnings of $0.09 per share when it actually produced earnings of $0.25, delivering a surprise of +177.78%.Over the last fo ...

The upcoming report from Lam Research (LRCX) is expected to reveal quarterly earnings of $1.20 per share, indicating an increase of 48.2% compared to the year-ago period. Analysts forecast revenues of $4.99 billion, representing an increase of 28.9% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a co ...

Wall Street analysts forecast that Altria (MO) will report quarterly earnings of $1.37 per share in its upcoming release, pointing to a year-over-year increase of 4.6%. It is anticipated that revenues will amount to $5.19 billion, exhibiting a decrease of 1.6% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.5% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections d ...

In its upcoming report, Equinix (EQIX) is predicted by Wall Street analysts to post quarterly earnings of $9.19 per share, reflecting a decline of 0.3% compared to the same period last year. Revenues are forecasted to be $2.26 billion, representing a year-over-year increase of 4.5%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this ...

Wall Street analysts forecast that Microsoft (MSFT) will report quarterly earnings of $3.35 per share in its upcoming release, pointing to a year-over-year increase of 13.6%. It is anticipated that revenues will amount to $73.71 billion, exhibiting an increase of 13.9% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior ...